No retraction, correction or concern found when last checked on Nov 1, 2026.
What Are the bona fide GSK3 Substrates?
Calum Sutherland
International Journal of Alzheimer’s Disease · 2011 · CC BY
Abstract
Nearly 100 proteins are proposed to be substrates for GSK3, suggesting that this enzyme is a fundamental regulator of almost every process in the cell, in every tissue in the body. However, it is not certain how many of these proposed substrates are regulated by GSK3 in vivo . Clearly, the identification of the physiological functions of GSK3 will be greatly aided by the identification of its bona fide substrates, and the development of GSK3 as a therapeutic target will be highly influenced by this range of actions, hence the need to accurately establish true GSK3 substrates in cells. In this paper the evidence that proposed GSK3 substrates are likely to be physiological targets is assessed, highlighting the key cellular processes that could be modulated by GSK3 activity and inhibition.
Cited by papers we hold 8
- Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials · 2023No notice
- Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances CD8+ T cell cytolytic killing of melanoma cells · 2022Not checked
- Targeting GSK3 and Associated Signaling Pathways Involved in Cancer · 2020No notice
- Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance · 2018No notice
- GSK3β regulates AKT-induced central nervous system axon regeneration via an eIF2Bε-dependent, mTORC1-independent pathway · 2016Not checked
- GSK-3 as potential target for therapeutic intervention in cancer · 2014No notice
- Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6 · 2014No notice
- Wnt/beta-Catenin Signaling and Small Molecule Inhibitors · 2013No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.